Highlights SANA AB

Stocks

SANION

SE0005794617

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm Other stock markets 17:00:00 20/07/2026 BST			5-day change	1st Jan Change
12.94 ^SEK	-0.77%		-4.08%	-38.96%

07-16	Syria seizes weapons hidden in tanker truck, says cargo was for Hezbollah	RE
07-06	France's Macron visits Syria, in first trip by an EU head of state since Assad toppled	RE

Highlights

05-26	Saniona AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-26	Saniona Q1 revenue SEK 4.6 mln	RE
04-07	Neurocrine to acquire Soleno in multi-billion dollar deal	FW
02-26	Saniona Q4 operating loss SEK 46.5 million	RE
02-26	Saniona AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
11-27	Saniona AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11-27	Saniona Q3 oper profit SEK 359.9 mln	RE
17/09/25	Workday rises after Elliott reveals $2 billion stake, endorses leadership	RE
16/09/25	Workday to acquire AI firm Sana for $1.1 billion	RE
04/09/25	Saniona Announces the Selection of San2668 as First-In-Class Clinical Candidate for Paediatric Epilepsy	CI
28/08/25	Saniona AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
28/08/25	Saniona Q2 operating loss widens to SEK 25.9 mln	RE
20/08/25	Jazz Pharmaceuticals plc Enters Exclusive Licensing Agreement with Saniona to Develop and Commercialize SAN2355	CI
25/06/25	Saniona Highlights Acadia Pharmaceuticals' Upcoming R&D Day	CI
19/06/25	Saniona Buys its Danish Headquarters in DKK49 Million Deal	MT
19/06/25	Saniona Acquires Headquarters In Glostrup, Denmark	RE
28/05/25	Saniona AB Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
28/05/25	Saniona Q1 Operating Loss At SEK 16.5 Mln	RE
27/05/25	Syria to re-open stock market starting June 2, finance minister says	RE
11/03/25	Saniona Extends Research Partnership for Potential Schizophrenia Treatments	MT
11/03/25	Saniona AB and Boehringer Ingelheim Extend Research Collaboration with One Year	CI
11/03/25	Saniona and Boehringer Ingelheim Extend Research Collaboration with One Year	CI
03/03/25	Acadia Pharmaceuticals and Saniona Announce Initial Positive Results from ACP-711 (formerly San711) Phase 1 Study	CI
27/02/25	Saniona AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2024	CI
27/02/25	Saniona AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024	CI